Trial Profile
Efficacy study of Fidaxomicin in patients with Clostridium-infections who failed to respond to oral vancomycin
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Sep 2016
Price :
$35
*
At a glance
- Drugs Fidaxomicin (Primary)
- Indications Clostridium difficile infections
- Focus Adverse reactions; Therapeutic Use
- 30 Sep 2016 New trial record